|
Market Closed -
OTC Markets
12:31:28 2026-06-04 EDT
|
5-day change | 1st Jan Change | ||
| 0.0290 USD | +6.62% |
|
+48.72% | -52.77% |
| 08-13 | CV Sciences, Inc., Q2 2026 Earnings Call, Aug 13, 2026 | |
| 08-13 | CV Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 3.79M | - | - | - | - | - |
| 994B | |||||
| 640B | - | - | - | ||
| 454B | |||||
| 337B | |||||
| 261B |
- Stock Market
- Stocks
- CVSI Stock
- Charts CV Sciences, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
